picamilon
Selected indexed studies
- Picamilon, a γ-aminobutyric acid (GABA) analogue and marketed nootropic, is inactive against 50 biological targets. (Basic Clin Pharmacol Toxicol, 2023) [PMID:36668678]
- [Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia]. (Zh Nevrol Psikhiatr Im S S Korsakova, 2024) [PMID:39269299]
- [Integrative assessment of the effectiveness and safety of outpatient use of Picamilon]. (Zh Nevrol Psikhiatr Im S S Korsakova, 2024) [PMID:39113452]
_Worker-drafted node — pending editorial review._
Connections
picamilon protects against
picamilon helps
Sources
- Picamilon, a γ-aminobutyric acid (GABA) analogue and marketed nootropic, is inactive against 50 biological targets. (2023) pubmed
- [Clinical efficacy and safety of Picamilon in patients with progressive chronic cerebral ischemia]. (2024) pubmed
- [Integrative assessment of the effectiveness and safety of outpatient use of Picamilon]. (2024) pubmed
- Determination of picamilon concentration in human plasma by liquid chromatography-tandem mass spectrometry. (2010) pubmed
- [Treatment of patients with chronic cerebral ischemia: experience of using the combined neuroprotective drug Picamilon Ginkgo]. (2022) pubmed
- Identification and quantification of vinpocetine and picamilon in dietary supplements sold in the United States. (2016) pubmed
- [Effects of aminalon, fenibut, and picamilon on the typological parameters of cerebral hemodynamics in swimmers with dysadaptation syndrome]. (2009) pubmed
- [Preclinical prognosis of pyracetam and picamilon safety based on acute toxicity data]. (2003) pubmed
- [The new cerebrovascular preparation pikamilon]. (1989) pubmed
- [Asthenia, mental fatigue and cognitive dysfunction]. (2023) pubmed